- Home
- BOH vs CLDX Comparison
BOH vs CLDX Comparison
Compare BOH & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOH
- CLDX
- Stock Information
- Founded
- BOH 1897
- CLDX 1983
- Country
- BOH United States
- CLDX United States
- Employees
- BOH N/A
- CLDX N/A
- Industry
- BOH Major Banks
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BOH Finance
- CLDX Health Care
- Exchange
- BOH Nasdaq
- CLDX Nasdaq
- Market Cap
- BOH 2.8B
- CLDX 2.9B
- IPO Year
- BOH N/A
- CLDX 2008
- Fundamental
- Price
- BOH $77.34
- CLDX $23.55
- Analyst Decision
- BOH Hold
- CLDX Buy
- Analyst Count
- BOH 5
- CLDX 8
- Target Price
- BOH $64.80
- CLDX $64.83
- AVG Volume (30 Days)
- BOH 381.6K
- CLDX 1.1M
- Earning Date
- BOH 10-28-2024
- CLDX 11-06-2024
- Dividend Yield
- BOH 3.61%
- CLDX N/A
- EPS Growth
- BOH N/A
- CLDX N/A
- EPS
- BOH 3.33
- CLDX N/A
- Revenue
- BOH $623,275,000.00
- CLDX $9,976,000.00
- Revenue This Year
- BOH N/A
- CLDX N/A
- Revenue Next Year
- BOH $5.06
- CLDX N/A
- P/E Ratio
- BOH $23.29
- CLDX N/A
- Revenue Growth
- BOH N/A
- CLDX 128.55
- 52 Week Low
- BOH $54.50
- CLDX $23.49
- 52 Week High
- BOH $81.45
- CLDX $53.18
- Technical
- Relative Strength Index (RSI)
- BOH 65.02
- CLDX 29.53
- Support Level
- BOH $76.78
- CLDX $25.56
- Resistance Level
- BOH $81.45
- CLDX $28.15
- Average True Range (ATR)
- BOH 1.96
- CLDX 1.62
- MACD
- BOH 0.23
- CLDX 0.14
- Stochastic Oscillator
- BOH 62.44
- CLDX 1.27
About BOH Bank of Hawaii Corporation
Bank of Hawaii Corp provides a broad range of financial products and services predominantly to customers in Hawaii, Guam, and other Pacific Islands. The Bank's subsidiaries are engaged in equipment leasing, securities brokerage, investment advisory services, and providing credit insurance. It is organized into three business segments for management reporting purposes: Consumer Banking, Commercial Banking, and Treasury and Other. Majority of the revenue is generated from Consumer Banking segment which offers a broad range of financial products and services, including loan, deposit and insurance products; private banking and international client banking services; trust services; investment management; and institutional investment advisory services.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.